[1]
R. A. Aladhab, “Association of empagliflozin treatment with changes in the metabolic score for insulin resistance in Iraqi adults with type 2 diabetes: a 6-month prospective cohort study”, Int J Basic Clin Pharmacol, Aug. 2026.